Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary-Reference-Cited by-同舟云学术

Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary

Published:2022-07-25 Issue:3 Volume:6 Page:119-124
ISSN:2399-3693
Container-title:Journal of Onco-Nephrology
language:en
Short-container-title:Journal of Onco-Nephrology

Author:

Vanhoutte Thomas¹^ORCID,Sprangers Ben¹²^ORCID

Affiliation:

1. Division of Nephrology, University Hospitals Leuven, Leuven, Belgium

2. Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute, KU Leuven, Leuven, Belgium

Abstract

The precise estimation of kidney function in patients with cancer is of great importance as deterioration and decreased kidney function are common and often kidney function-based dose adjustments of chemotherapy and other cancer-related medicines are necessary in these patients. There is an ongoing debate regarding the most suitable technique to determine kidney function based on the availability, accuracy, and validation of available glomerular filtration rate-estimating formulas in patients with cancer. Recent data suggest that cystatin-based formulas are superior to creatinine-based GFR formulas not only in the general population but also in patients with cancer.

Funder

The Research Foundation Flanders

fundación científica asociación española contra el cáncer

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/23993693221114901

Reference50 articles.

1. How to assess kidney function in oncology patients

2. How to determine kidney function in cancer patients?

3. Estimation of Kidney Function in Oncology

4. GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer

5. Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review